COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
4.010
+0.180 (4.70%)
At close: Aug 30, 2024, 4:00 PM
3.950
-0.060 (-1.50%)
After-hours: Aug 30, 2024, 6:28 PM EDT
COSCIENS Biopharma Employees
COSCIENS Biopharma had 12 employees as of December 31, 2020. The number of employees decreased by 44 or -78.57% compared to the previous year.
Employees
12
Change
-44
Growth
-78.57%
Revenue / Employee
$409,583
Profits / Employee
-$1,519,167
Market Cap
12.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareMax | 1,450 |
| Star Equity Holdings | 171 |
| Psychemedics | 116 |
| Senti Biosciences | 48 |
| Oncternal Therapeutics | 30 |
| Moleculin Biotech | 18 |
| QT Imaging Holdings | 14 |
| Autonomix Medical | 8 |
CSCI News
- 4 days ago - COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 18 days ago - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 24 days ago - Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc. - GlobeNewsWire
- 6 weeks ago - Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders - GlobeNewsWire
- 2 months ago - Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 3 months ago - Aeterna Zentaris and Ceapro Complete Merger Transaction - GlobeNewsWire
- 3 months ago - Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date - GlobeNewsWire
- 3 months ago - Aeterna Zentaris Announces Details Regarding Transaction with Ceapro - GlobeNewsWire